Thompson Siegel & Walmsley LLC raised its holdings in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 41.4% in the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,389,010 shares of the medical instruments supplier’s stock after buying an additional 406,654 shares during the period. Thompson Siegel & Walmsley LLC owned about 0.61% of DENTSPLY SIRONA worth $83,076,000 as of its most recent SEC filing.

A number of other large investors have also modified their holdings of the stock. Macquarie Group Ltd. boosted its holdings in DENTSPLY SIRONA by 19.7% during the third quarter. Macquarie Group Ltd. now owns 2,077,278 shares of the medical instruments supplier’s stock worth $124,248,000 after buying an additional 342,160 shares in the last quarter. Ameriprise Financial Inc. boosted its holdings in DENTSPLY SIRONA by 22.5% during the third quarter. Ameriprise Financial Inc. now owns 1,864,139 shares of the medical instruments supplier’s stock worth $111,487,000 after buying an additional 342,967 shares in the last quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund boosted its holdings in DENTSPLY SIRONA by 10.3% during the third quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund now owns 58,519 shares of the medical instruments supplier’s stock worth $3,500,000 after buying an additional 5,473 shares in the last quarter. Comerica Bank boosted its holdings in DENTSPLY SIRONA by 2.8% during the third quarter. Comerica Bank now owns 61,335 shares of the medical instruments supplier’s stock worth $3,759,000 after buying an additional 1,645 shares in the last quarter. Finally, Massey Quick Simon & CO. LLC bought a new stake in DENTSPLY SIRONA during the third quarter worth approximately $124,000. Hedge funds and other institutional investors own 94.68% of the company’s stock.

XRAY has been the subject of a number of research reports. BidaskClub cut shares of DENTSPLY SIRONA from a “hold” rating to a “sell” rating in a report on Friday, July 28th. Zacks Investment Research downgraded shares of DENTSPLY SIRONA from a “hold” rating to a “sell” rating in a research report on Monday, October 30th. Morgan Stanley restated an “overweight” rating and issued a $69.00 price target (up previously from $67.00) on shares of DENTSPLY SIRONA in a research report on Friday, October 6th. HC Wainwright restated a “buy” rating and issued a $68.00 price target on shares of DENTSPLY SIRONA in a research report on Monday, November 6th. Finally, Cleveland Research downgraded shares of DENTSPLY SIRONA from a “buy” rating to a “neutral” rating in a research report on Thursday, October 5th. Three equities research analysts have rated the stock with a sell rating, two have given a hold rating and seven have issued a buy rating to the company’s stock. The company presently has an average rating of “Hold” and a consensus price target of $67.00.

In related news, CFO Nicholas W. Alexos bought 50,000 shares of the business’s stock in a transaction on Monday, November 13th. The stock was bought at an average price of $65.85 per share, for a total transaction of $3,292,500.00. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Francis J. Lunger sold 8,900 shares of the stock in a transaction that occurred on Monday, November 13th. The stock was sold at an average price of $65.90, for a total transaction of $586,510.00. The disclosure for this sale can be found here. 1.99% of the stock is owned by corporate insiders.

ILLEGAL ACTIVITY WARNING: This piece of content was published by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are viewing this piece of content on another website, it was illegally copied and republished in violation of US and international copyright & trademark laws. The legal version of this piece of content can be viewed at https://theolympiareport.com/2017/11/20/thompson-siegel-walmsley-llc-raises-position-in-dentsply-sirona-inc-xray.html.

DENTSPLY SIRONA Inc. (XRAY) traded up $0.37 during mid-day trading on Monday, reaching $67.55. 1,391,800 shares of the company’s stock were exchanged, compared to its average volume of 1,651,487. DENTSPLY SIRONA Inc. has a 12 month low of $52.53 and a 12 month high of $67.95. The company has a current ratio of 2.32, a quick ratio of 1.59 and a debt-to-equity ratio of 0.21. The stock has a market cap of $15,515.08, a P/E ratio of 26.91, a price-to-earnings-growth ratio of 2.67 and a beta of 1.27.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its earnings results on Friday, November 3rd. The medical instruments supplier reported $0.70 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.66 by $0.04. DENTSPLY SIRONA had a negative net margin of 20.33% and a positive return on equity of 7.56%. The company had revenue of $1.01 billion during the quarter, compared to the consensus estimate of $978.99 million. During the same quarter in the prior year, the firm earned $0.66 EPS. The company’s revenue was up 5.8% compared to the same quarter last year. analysts expect that DENTSPLY SIRONA Inc. will post 2.66 EPS for the current fiscal year.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.